U.S. Markets closed

JNJ or PFE: Comparing Legacy and Newly Launched Immunology Drugs

Margaret Patrick
JNJ or PFE: Comparing Legacy and Newly Launched Immunology Drugs

Johnson & Johnson or Pfizer: Which Is the Best Pick in April?(Continued from Prior Part)Legacy immunology drugs In the first quarter, Johnson & Johnson (JNJ) reported Remicade sales worth $1.10 billion, a YoY (year-over-year) fall of 20.6% on